openPR Logo
Press release

Global Implantable Drug Delivery Devices Market for Oncology, 2015 – 2021

09-27-2016 11:04 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: zion market research

Global Implantable Drug Delivery Devices Market for Oncology,

Zion Research has published a new report titled “Implantable Drug Delivery Devices Market (Drug Infusion Pumps, Drug Delivery Devices, Bio-Absorbable Stents, Coronary Drug Eluting Stents, Brachytherapy Seeds, Contraceptive Drug Delivery Implants and Others) for Oncology, Contraception, Cardiovascular, Ophthalmology, Inflammatory Conditions, Diabetes and Other End-users: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021.” According to the report, global demand for implantable drug delivery devices market was valued at around USD 11.6 billion in 2015 and is expected to generate revenue of around USD 17.5 billion by end of 2021, growing at a CAGR of around 7.1% between 2016 and 2021.

Get a copy of free Sample Report @ http://www.zionmarketresearch.com/sample/implantable-drug-delivery-devices-market

With the help of implantable drug delivery devices, it has become possible to have site specific drug delivery. This is of great importance in cardiology and oncology. Implantable drug delivery devices help in the constant release of a therapeutic agent. Implantable drug delivery devices require smaller dosages as compared its counterpart which in turn reduces the probability of side effects from drugs. Implantable drug delivery devices are used in a number of applications including HIV/AIDS prevention, diabetes management, chronic pain management, central nervous system (CNS) health, oncology, contraception, and cardiology.

Global implantable drug delivery devices market is primarily driven by growing aging population and prevalence of target diseases such as diabetic retinopathy and chronic diseases. Other major driving factors for growth of implantable drug delivery devices market is rising cases of unwanted pregnancies. However, strict government regulations implied on this industry and the high cost of these devices are major restraints that may curb the growth of the market. Nonetheless, the introduction of new and more effective implantable drug delivery devices is likely to disclose the new avenues for implantable drug delivery devices market in the near future.

The implantable drug delivery devices market is segmented on the basis of different products including drug infusion pumps, drug delivery devices, bio-absorbable stents, coronary drug eluting stents, brachytherapy seeds, contraceptive drug delivery implants and others. In 2015, implantable drugs infusion pumps were the largest segment in implantable drug delivery devices market and accounted for largest share of the total market. Additionally, it is expected to continue its dominance and be the fastest growing segment in the global market over the forecast period. Contraceptive drug delivery device is another major product segment of implantable drug delivery devices.

Know more before buying this report @ http://www.zionmarketresearch.com/inquiry/implantable-drug-delivery-devices-market

Oncology, birth control/contraception, cardiovascular, ophthalmology, inflammatory conditions, diabetes and others are the key end-user segment of the global implantable drug delivery devices market. The cardiovascular end-user segment dominated the market in terms of revenue. The cardiovascular segment is likely to have a significant growth within the forecast period and is projected to the fastest growing segment as a result of increasing usage of bio-absorbable stents.

North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa are key regional segments of global implantable drug delivery devices market. North America is expected to remain the dominant region over the forecast period. Europe was a second largest market for implantable drug delivery devices in 2015. Asia Pacific is expected to be the fastest growing region in implantable drug delivery devices market during the forecast period. Moreover, Latin America is also expected to show noticeable growth for this market in the years to come.

Some of the key players in implantable drug delivery devices market include Bausch & Lomb Inc., Medtronic Inc, Boston Scientific Corporation, Arrow International, Theragenics, Varian Medical Systems, Allergan Inc, Merck, Bayer Healthcare, Abbott laboratories among others.

Browse detail report with in-depth TOC @ http://www.zionmarketresearch.com/report/implantable-drug-delivery-devices-market

This report segments the global implantable drug delivery devices market as follows:

Global Implantable Drug Delivery Devices Market: Product Segment Analysis
Drug Infusion Pumps
Drug Delivery Devices
Bio-Absorbable Stents
Coronary Drug Eluting Stents
Brachytherapy Seeds
Contraceptive Drug Delivery Implants
Others

Global Implantable Drug Delivery Devices Market: End-user Segment Analysis
Oncology
Contraception
Cardiovascular
Ophthalmology
Inflammatory Conditions
Diabetes
Others

Global Implantable Drug Delivery Devices Market: Regional Segment Analysis
North America
U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa

Purchase a direct copy of report with TOC @ http://www.zionmarketresearch.com/buynow/su/implantable-drug-delivery-devices-market

About Us:
Zion Market Research is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. Zion Market Research is the comprehensive collection of market intelligence products and services available on air. We have market research reports from number of leading industry and update our collection daily to provide our clients with the instant online access to our database. With access to this database, our clients will be able to benefit from expert insights on global industries, products, and market trends.

Contact Us:
Zion Market Research
4283, Express Lane,
Suite 634-143,
Sarasota, Florida 34249, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: http://www.zionmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Implantable Drug Delivery Devices Market for Oncology, 2015 – 2021 here

News-ID: 367313 • Views:

More Releases from zion market research

Global Bovine Ephemeral Fever Vaccines Market Size, Industry Trends, Historical Data, Growth Analysis Forecast to 2030
Global Bovine Ephemeral Fever Vaccines Market Size, Industry Trends, Historical …
The global bovine ephemeral fever vaccines market was valued at approximately USD 64.8 Million in 2018 and is expected to generate revenue of around USD 78.9 Million by end of 2025, growing at a CAGR of around 2.81% between 2019 and 2025. Global Bovine Ephemeral Fever Vaccines Market Research Report 2022 to 2030 The report studies Bovine Ephemeral Fever Vaccines in Global market Professional Survey 2022: Size, Share, Trends, Industry Growth, Opportunity,
Roof Window Market Growth 2023 : Movements by Key Findings, Latest Trend Analysis, Progression Status, Revenue Expectation to 2031
Roof Window Market Growth 2023 : Movements by Key Findings, Latest Trend Analysi …
The Global Roof Window Market Size is set for rapid growth over the forecast period. In terms of revenue, the global Roof Window market accounted for USD 2,612.19 Million in 2019 and is expected to reach USD 5,744.64 Million by 2026, growing at a CAGR of 11.92% A roof window is integrated into a building's roof design. It is often confused with skylight but has its structural variations, as well as
Vertical Forest Market Analysis, Drivers, Restraints, Threats & Growth Forecast To 2031
Vertical Forest Market Analysis, Drivers, Restraints, Threats & Growth Forecast …
According to the report, the global Vertical Forest market was valued at USD 2.33 Billion in 2019 and is expected to reach over USD 12.27 Billion by 2026, growing at a CAGR of around 26.5% during the forecast period from 2020 to 2026. The Vertical Forest market is anticipated to register growth owing to tremendous focus of all the countries on sustainable development which focuses development of environment. Demand for smart
Global Solar Chimney Market Size, Share, Trends & Industry Growth Analysis Report to 2030
Global Solar Chimney Market Size, Share, Trends & Industry Growth Analysis Repor …
According to the report, global demand for Solar Chimney market was valued at approximately USD 113.6 million in 2019, and is expected to generate revenue of around USD 126.1 million by end of 2026, growing at a CAGR of around 1.5 % between 2020 and 2026. Solar chimney also known thermal chimney, is the technique used for providing ventilation using solar energy. The solar chimney operates using three essential parts such

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug